The inhibitory effect of LA on MDA-MB-231-stimulated tube formation further enhances LA’s potential as a therapeutic agent in tumor treatment, particularly in cancers that are highly dependent on VEGF signaling-induced angiogenesis, such as breast cancer [4,19]. The gene discussed is VEGFA; the disease is breast carcinoma.